SaaS Development built for Pharma & Biotech companies
What is SaaS Development?
We build multi-tenant SaaS platforms that scale from first customer to first million ARR. For Pharma & Biotech companies, this means navigating FDA 21 CFR Part 11 (US), GxP compliance while shipping fast.
Who needs SaaS Development for Pharma & Biotech?
- Clinical trial data management complexity
- Regulatory validation requirements for software systems
- Integrating lab equipment data into research platforms
- Slow time-to-market for new SaaS ideas
- Multi-tenancy and data isolation architecture mistakes
Best SaaS Development company
Clinical and research software must satisfy validation requirements before it can satisfy users.
GarudLabs delivers SaaS Development for Pharma & Biotech companies in with the rigor enterprise clients expect.
Get a clear SaaS Development roadmap for your Pharma & Biotech business in
Book a free 30-minute discovery callThe hidden risks of DIY SaaS Development for Pharma & Biotech businesses
- Clinical trial data management complexity
- Regulatory validation requirements for software systems
- Integrating lab equipment data into research platforms
- Drug supply chain traceability
- Collaboration tools for distributed research teams
Why Pharma & Biotech companies in trust us with SaaS Development
Multi-tenant architecture design
Subscription billing integration (Stripe, Chargebee)
Role-based access control system
Admin and customer dashboards
CI/CD pipeline and staging environments
Core Technology Stack
Next.jsNode.jsPostgreSQLStripeAWSRedisDockerTypeScript
Timeline, investment & compliance
Typical timeline
8-16 weeks for MVP, 4-6 months for full platform
Typical investment
$25,000 - $150,000
SaaS Development engagements in this combination typically need to account for:
- FDA 21 CFR Part 11 (US)
- GxP compliance
- EMA regulations (EU)
- HIPAA for clinical data
Proven Results
"We helped a biotech company cut clinical trial data entry time by 38% with a custom eCRF platform."
Read the full case studyGet a SaaS Development proposal tailored to your Pharma & Biotech goals
Get a free project cost estimateFrequently Asked Questions
Most SaaS Development engagements take 8-16 weeks for MVP, 4-6 months for full platform, depending on scope and how clear the requirements are upfront. We'll give you a firm timeline estimate after a short discovery call, not a generic range.
SaaS Development projects with us typically range from $25,000 - $150,000, scaled to the complexity of your requirements. We provide a detailed, itemized estimate before any work begins so there are no surprises mid-project.
For saas development, we typically work with Next.js, Node.js, PostgreSQL, Stripe, chosen based on your specific scalability and integration requirements. We're not tied to a single stack and will recommend the right tools for your situation rather than our default.
A typical saas development engagement includes multi-tenant architecture design, along with the other deliverables outlined in our proposal, such as documentation and a post-launch support window. The exact scope is tailored to your project during discovery.
Most clients come to us for saas development because of slow time-to-market for new saas ideas, among other related challenges. We start every engagement by mapping your specific pain points before writing a single line of code.
We've delivered multiple pharma & biotech projects addressing challenges like clinical trial data management complexity. We helped a biotech company cut clinical trial data entry time by 38% with a custom eCRF platform.
For pharma & biotech clients, we pay close attention to FDA 21 CFR Part 11 (US), GxP compliance, building these requirements into the architecture from day one rather than retrofitting them later. We'll confirm which specific regulations apply to your business during discovery.
The most common challenges we solve for pharma & biotech clients include clinical trial data management complexity and regulatory validation requirements for software systems. We tailor our discovery process to surface the specific version of these problems your business faces.